Parallax Volatility Advisers’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100,000
Closed -$1.02M 2007
2020
Q4
$1.02M Hold
100,000
﹤0.01% 1432
2020
Q3
$350K Buy
+100,000
New +$475K ﹤0.01% 2360
2019
Q1
Sell
-24,200
Closed -$158K 3682
2018
Q4
$158K Hold
24,200
﹤0.01% 1804
2018
Q3
$417K Buy
+24,200
New +$360K ﹤0.01% 1478
2016
Q4
Sell
-9,182
Closed -$255K 3831
2016
Q3
$255K Sell
9,182
-91,718
-91% -$2.43M ﹤0.01% 1759
2016
Q2
$2.46M Buy
+100,900
New +$2.86M ﹤0.01% 860
2016
Q1
Sell
-15,135
Closed -$452K 3344
2015
Q4
$452K Buy
+15,135
New +$510K ﹤0.01% 1588

Other funds holding PGEN

Parallax Volatility Advisers's PGEN Position: Q1 2021 in Review

Parallax Volatility Advisers sold out of Precigen (PGEN) in Q1 2021, closing a stake of 9,402 shares — an estimated $96K sold.

Parallax Volatility Advisers first reported a position in PGEN in Q2 2016 and held it in 7 quarters. The position peaked at $2.71M in Q2 2016. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2021.

  • Parallax Volatility Advisers reported no remaining Precigen position as of Q1 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 9,402 Precigen shares in Q1 2021, an estimated $96K.
  • Parallax Volatility Advisers first reported a position in Precigen in Q2 2016 and held it in 7 quarters.
  • Parallax Volatility Advisers's Precigen position peaked at $2.71M in Q2 2016.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q1 2021.

Based on Parallax Volatility Advisers's 13F filing for Q1 2021, filed 14 May 2021.